The cornea, which is the clear, transparent outer layer at the front of the eye, can get severely damaged during accidents ...

US FDA grants fast track designation to OKYO Pharma’s urcosimod to treat neuropathic corneal pain: London Saturday, May 3, 2025, 17:00 Hrs [IST] OKYO Pharma Limited, an ophthalm ...

Nowadays, when outdoor activities increase with warm air, more and more people complain of itchy and redness due to ...

Urcosimod has received FDA fast track designation for neuropathic corneal pain, enabling expedited regulatory processes and ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod ...

Learning to deal with complicated cases and difficult situations, whether predictable or completely unexpected, is an important part of the skill set of a surgeon.The needed tools are not only ...

Urcosimod phase 2 trial treating Neuropathic Corneal Pain ("NCP”) patients was initiated in October 2024 and designed as a ...

Causes of blurry vision can be directly related to eye health — including refractive and nonrefractive errors — or caused by ...

Living-related conjunctival limbal allograft should be first-line therapy for limbal stem cell deficiency, Edward J. Holland, ...

Researchers reported long-term refractive outcomes in patients undergoing cataract surgery with Hydrus implantation compared ...

Along with television, he has acted in films such as A Stray Goat and The Dude in Me. He also provided his voice for the Korean dub of Sing 2 as Johnny. On January 18, 2023, he released his first-ever ...